Related Experiment Video

Updated: Jun 22, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Angiogenesis regulated by VEGF and its receptors and its clinical application

Masabumi Shibuya

    [Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
    |June 2, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
    09:03

    Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

    Published on: June 30, 2023

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
    09:03

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

    Published on: November 23, 2014

    Related Experiment Videos

    Last Updated: Jun 22, 2026

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
    09:04

    A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

    Published on: March 15, 2016

    Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
    09:03

    Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

    Published on: June 30, 2023

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
    09:03

    Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

    Published on: November 23, 2014

    Related Concept Videos

    Regulation of Angiogenesis and Blood Supply01:24

    Regulation of Angiogenesis and Blood Supply

    Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
    Mechanism of Angiogenesis01:10

    Mechanism of Angiogenesis

    Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

    Articles linked to this work by shared authors, journal, and citation graph.

    7MeERT Enhances Antibody-Drug Conjugate Efficacy in Glioblastoma by Inducing AMPK-p38MAPK-Mediated Non-Canonical Endocytosis of EGFRvIII.

    Anti-cancer agents in medicinal chemistry·2026

    Human trophoblast stem cell-differentiated syncytiotrophoblasts as a model for hypoxia-enhanced secretion of the anti-angiogenic factor sFLT1.

    Experimental cell research·2025

    Inhibition of VEGFR1 TK Signaling in Peritoneal Macrophages Suppresses Endometriosis Development.

    In vivo (Athens, Greece)·2025

    Enhanced Anticancer Activity of 7MeERT over Ertredin: A Comparative Study on Cancer Cell Proliferation and NDUFA12 Binding.

    Biomolecules·2024

    VEGFR1 TK signaling protects the lungs against LPS-induced injury by suppressing the activity of alveolar macrophages and enhancing the anti-inflammatory function of monocyte-derived macrophages.

    Toxicology and applied pharmacology·2024

    NDUFA12 as a Functional Target of the Anticancer Compound Ertredin in Human Hepatoma Cells As Revealed by Label-Free Chemical Proteomics.

    Journal of proteome research·2023

    [Treatment landscape of mature NK/T-cell lymphomas: treatment outcomes in Japan and future prospects].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic or pre-emptive therapy with azacitidine or FLT3 inhibitor after allogeneic hematopoietic stem cell transplantation for AML and MDS].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Prophylactic use of tyrosine kinase inhibitors after allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Complement-coagulation crosstalk in immunothrombosis].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    Recent advances in cell therapy for AML/MDS.

    International journal of hematology·2026

    Therapeutic effects of trans-3-methoxy-β-nitrostyrene in rat model of monocrotaline-induced pulmonary hypertension.

    European journal of pharmacology·2026

    A dual functional hybrid lipid-polymeric nanoparticle co-loaded coenzyme Q10 and siRNA TNFα for anti-inflammatory skin therapy.

    International journal of pharmaceutics·2026

    Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis.

    Cell reports. Medicine·2026

    Preclinical evaluation of entecavir as a fetal hemoglobin inducer using in vitro, in vivo, network pharmacology, and molecular docking approaches.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

    Extracorporeal photopheresis: A comprehensive review from a transfusion medicine perspective.

    Hematology, transfusion and cell therapy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us